Management Team

Erica J. Rogers - President & CEO

Erica Rogers is the President and CEO of Silk Road Medical. Prior to Silk Road Medical, Erica was the COO of Medicines360, a non-profit pharmaceutical company developing drugs and devices for women. Erica was the founder and CEO of Allux Medical, as well as the co-founder of Visiogen, which was acquired by Abbott Medical Optics in 2009. Erica spent over 12 years at Boston Scientific, in sales and marketing positions. She began her career in pharmaceutical sales after receiving a B.S. in zoology from San Diego State University. Erica holds five issued and 15 pending US patents in medical devices and nanotechnology.

Dr. Sumaira Macdonald - Chief Medical Officer

Sumaira Macdonald, MD, PhD is the Chief Medical Officer at Silk Road Medical. Prior to joining Silk Road Medical Inc., Dr. Macdonald was a Vascular Radiologist and Honorary Clinical Senior Lecturer at Newcastle University and the Freeman Hospital, Newcastle upon Tyne, UK. Dr. Macdonald is well regarded for her career-long efforts to improve endovascular interventions. In addition to being the Co-Editor of the Springer “Carotid Stenting; A Practical Guide”, Dr. Macdonald has authored over 70 medical publications on vascular disease, is the recipient of many academic society honors, serves on the editorial boards of a number of scientific journals and is highly sought after as a speaker, having given over 300 international lectures.

Richard Ruedy - Executive VP of Clinical, & Regulatory Affairs, and Quality Assurance

Ric Ruedy joined Silk Road in 2011 and is the Executive Vice President of Clinical and Regulatory Affairs, and Quality Assurance. Ric brings to Silk Road Medical 25 years of experience in the Regulatory, Clinical and Quality areas for both multi-national corporations and venture-backed start-ups. Prior to Silk Road Medical, Ric served as Vice President of Regulatory, Clinical and Quality for Nevro Corporation and, earlier, at Cardica, Inc. Ric also served as Director of Regulatory Affairs at Abbott Vascular, where he obtained the second carotid stent approval in the United States. Ric is a co-founder of Acta Vascular (acquired by Covidien) and held positions of increasing responsibility at Edwards Lifescienses, Medtronic, TriPath Imaging (acquired by Becton Dickinson), and Parallax Medical (acquired by Arthrocare). Ric has a B.A. in English and International Relations from Bucknell University.

Lucas Buchanan - Chief Financial Officer

Lucas Buchanan leads finance, strategy, corporate development, business development, and reimbursement efforts for Silk Road Medical. Prior to joining the company full time in 2012, Lucas was an investment professional with The Vertical Group, the founding investor in Silk Road, where he helped lead the company through early development and financing milestones while charting the company’s commercial strategy. Also while at The Vertical Group, Lucas led investments in Atheromed (acquired by Volcano Corporation) and Lutonix (acquired by CR Bard). Lucas has also held various leadership positions in marketing and corporate development/M&A at Impax Laboratories and Medtronic and began his career at Ernst & Young Corporate Finance LLC where he advised healthcare companies on financing and M&A transactions. Lucas holds a B.A. in Economics from Duke University and an M.B.A. in Health Care Management from The Wharton School at the University of Pennsylvania.

Andrew S. Davis - Executive VP of Global Sales

Andrew Davis joined Silk Road Medical in May of 2015 and is the Executive Vice President of Global Sales. Andrew brings to Silk Road Medical over 20 years of experience in the medical device field with deep expertise in launching innovative, minimally invasive therapies that increase patient access and solve unmet clinical needs in cardiovascular diseases. Prior to joining Silk Road Medical, Andrew was the Vice President of Sales and Marketing at Acelity’s Advanced Wound Therapy Group. Prior to Acelity, he spent 15yrs at Medtronic and held Vice President of Sales positions for Structural Heart CoreValve, Endovascular AAA/TAA, Peripheral and Spinal/Biologics divisions. Andrew began his career in pharmaceutical sales at Johnson and Johnson after receiving a B.S. in Political Science from Florida State University.

Mark Caires - Vice President of Finance & Administration

Mark Caires is the Vice President of Finance & Administration at Silk Road Medical. Mark brings with him over 20 years of financial expertise in small and start-up companies. Prior to Silk Road Medical, Mark was the Senior Director of Finance and Administration at Broncus Technologies, Inc.  Mark received his B.S. in Mathematics and Economics from Santa Clara University in 1987 and his M.B.A in Finance from San Diego State University.

Mark Page – Vice President, Marketing

Mark joined Silk Road Medical in 2014 and brings with him over 20 years of medical device sales and marketing experience. Mark most recently served as Vice President of Marketing and Professional Education for the privately held arterial access device company Arstasis, Inc. Prior to Arstasis, Mark was VP, Marketing & International Sales at FlowCardia, Inc., a venture-backed chronic total occlusion device company that was successfully acquired by the Peripheral Vascular division of CR Bard for 8x revenue. Mark also has 8 years of Coronary and Neurovascular marketing experience at Boston Scientific receiving back to back “Marketing Manager of the Year” awards in both divisions. Mark started his professional career with 5 years of consumer product sales, then transitioned to medical device sales with Kendall Healthcare in their anesthesia and critical care division. Mark holds a B.S. in Marketing from Fairfield University in Connecticut.

  • ©2016 Silk Road Medical

  • 735 North Pastoria Avenue, Sunnyvale, CA 94085

    phone: 855.410.TCAR (8227)
    local phone: 408.720.9002
    fax: 408.720.9013